Transformational leadership in drug discovery by way of virtuous thought, word and deed.
Sawyer
Tomi K
TK
Editor-in-Chief, Chemical Biology & Drug Design Chief Scientific Officer and Senior Vice-President, Drug Discovery and Innovative Technologies, Aileron Therapeutics, Cambridge, MA, USA Adjunct Professor, Chemistry and Biochemistry & Molecular Biology, University of Massachusetts, Amherst, MA, USA Adjunct Professor, Cancer Biology, Advisor, Chemical Biology Program, University of Massachusetts Medical School, Worcester, MA, USA Email: editor@cbdd.org.
D015195:Drug Design; D004345:Drug Industry; D013678:Technology, Pharmaceutical